Clinical Trial Detail

NCT ID NCT01844674
Title A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

Advanced Solid Tumor

melanoma

Therapies

Tizanidine + Vemurafenib

Age Groups: adult senior

Additional content available in CKB BOOST